Please wait
0001453593
EX-FILING FEES
0.0001381
0001453593
2025-11-10
2025-11-10
0001453593
1
2025-11-10
2025-11-10
iso4217:USD
xbrli:shares
iso4217:USD
xbrli:shares
xbrli:pure
Exhibit
107
Calculation
of Filing Fee Tables
Form
S-8
(Form
Type)
Xtant
Medical Holdings, Inc.
(Exact
Name of Registrant as Specified in its Charter)
Table
1: Newly Registered Securities
Fees Previously Paid
| Security Type | |
Security Class Title | |
Fee Calculation Rule | |
Amount Registered(1) | |
Proposed Maximum Offering Price Per Unit(2) | |
Maximum Aggregate Offering Price | |
Fee Rate | |
Amount of Registration Fee(3) |
| Equity | |
Common Stock, par value $0.000001 per share | |
457(c) and 457(h) | |
12,300,000 shares | |
$ | 0.77 | | |
$ | 9,471,000 | | |
| $138.10 per $1,000,000 | | |
$ | 1,308 | |
| Total Offering Amounts | | |
$ | 9,471,000 | | |
| | | |
$ | 1,308 | |
| Total Fee Offsets | | |
| | | |
| | | |
| 0 | |
| Net Fee Due | | |
| | | |
| | | |
$ | 1,308 | |
| (1) | Pursuant
to Rule 416 under the Securities Act of 1933, as amended (Securities Act), this registration
statement will also cover any additional shares of common stock, par value $0.000001 per
share, of Xtant Medical Holdings, Inc. (Common Stock) that become issuable under the Xtant
Medical Holdings, Inc. 2023 Equity Incentive Plan (as amended and restated, the 2023 Plan)
by reason of any stock split, stock dividend, recapitalization or other similar transaction
effected without the registrant’s receipt of consideration which would increase the
number of outstanding shares of Common Stock. |
| | |
| (2) | Estimated
solely for the purpose of calculating the amount of the registration fee and calculated pursuant
to Rule 457(c) and Rule 457(h) under the Securities Act on the basis of the average of the
high and low sales prices of the Common Stock on November 7, 2025, as reported by the NYSE
American. |
| | |
| (3) | The
Registrant does not have any fee offsets. |
N/A